Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol ®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects

Ezetimibe is a new class of antihyperlipidemic agent indicated for the prevention of atherosclerosis disease and for the treatment of hypercholesterolemia. Information on the pharmacokinetic profiles of ezetim...

Source: BMC Clinical Pharmacology - February 3, 2023 Category: Drugs & Pharmacology Authors: Feifei Sun, Yanping Liu, Ting Li, Pingping Lin, Xin Jiang, Xin Li, Chenjing Wang, Xiaomeng Gao, Yaping Ma, Yao Fu and Yu Cao Tags: Research article Source Type: research